SINO BIOPHARMACEUTICAL (SBMFF:OTCMKTS)

$0.7 -0.0009 (-0.1284%)

watchlist-icon
search-icon
Profile Icon

Most Recent Average Sentiment Analysis Score (0 to 100): 64

negative-sentiment
Negative [0, 35)
neutral-sentiment
Neutral [35, 65]
positive-sentiment
Positive (65, 100]
Visualize Sentiment Trendline

Analysed SINO BIOPHARMACEUTICAL (SBMFF:OTCMKTS) News Sources

I-Mab Announces Intention to Undertake Strategic Transformation to Global Biotech Platform, to Pursue Hong Kong IPO, and Rebrand as NovaBridge Biosciences

16-10-2025

yahoo.com

What Do Recent Swings and Cash Flow Growth Mean for Sino Biopharm’s 2025 Value?

19-10-2025

yahoo.com

Sino Biopharmaceutical Limited Unveils New Global Brand, SBP Group, to Accelerate International Expansion

19-08-2026

yahoo.com

SINO BIOPHARMACEUTICAL (SBMFF:OTCMKTS) Sentiment Trend

0 25 50 75 100 59 72 61 16-10-2025 19-10-2025 19-08-2026 #1 #2 #3 Negative < 35 Neutral 35–65 Positive > 65 View FAQ

SINO BIOPHARMACEUTICAL (SBMFF:OTCMKTS) FAQs

toggle

What is the current price of SINO BIOPHARMACEUTICAL (SBMFF:OTCMKTS)?

The current price of SINO BIOPHARMACEUTICAL (SBMFF:OTCMKTS) is $0.7.


toggle

SINO BIOPHARMACEUTICAL (SBMFF:OTCMKTS) absolute price change since previous trading day?

The absolute price change of SINO BIOPHARMACEUTICAL (SBMFF:OTCMKTS) since the previous trading day is $-0.0009.


toggle

SINO BIOPHARMACEUTICAL (SBMFF:OTCMKTS) percentage price change since previous trading day?

The percentage price change of SINO BIOPHARMACEUTICAL (SBMFF:OTCMKTS) since the previous trading day is -0.1284%.


toggle

What is the most recent average sentiment score for SINO BIOPHARMACEUTICAL (SBMFF:OTCMKTS)?

The most recent average sentiment score for SINO BIOPHARMACEUTICAL (SBMFF:OTCMKTS) is 64 out of 100.


toggle

What is the most recent average sentiment for SINO BIOPHARMACEUTICAL (SBMFF:OTCMKTS)?

The most recent sentiment for SINO BIOPHARMACEUTICAL (SBMFF:OTCMKTS) is .


SEC-8K** Filing Available For SINO BIOPHARMACEUTICAL (SBMFF:OTCMKTS)

** material developments that could impact a company's financial condition or stock price.

Author: MattELab

X Icon

GitHub Icon

MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.